Leadership, Planning and Evaluation (LPE)

领导力、规划和评估（LPE）

• 批准号: 10628437
• 负责人: Robert A. Winn
• 金额: $ 33.83万
• 依托单位: VIRGINIA COMMONWEALTH UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1995
• 资助国家: 美国
• 起止时间: 1995-12-01 至 2028-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10628437
• 关键词: Accountability; Address; Advisory Committees; Area; Articulation; Award; Behavioral; Biology; COVID-19 pandemic; Cancer Biology; Cancer Center; Cancer Center Support Grant; Cancer health equity; Catchment Area; Charge; Clinical; Clinical Research; Clinical Trials; Collaborations; Communities; Community Outreach; Creativeness; Development; Disease; Education; Ensure; Evaluation; Extramural Activities; Faculty; Faith; Fostering; Foundations; Funding; Future; Gender; Goals; Grant; Growth; Health; Infrastructure; Institution; Investments; Leadership; Malignant Neoplasms; Medicine; Mission; Monitor; NCI Center for Cancer Research; National Cancer Institute; Outcome; Peer Review; Policy Developments; Positioning Attribute; Principal Investigator; Protocols documentation; Race; Research; Research Personnel; Research Training; Resource Allocation; Resource Sharing; Resources; Risk; Science; Services; Shapes; Social Distance; Strategic Planning; Structure; Students; System; Technology; Training and Education; Translations; Trust; Universities; Vaccination; Virginia; Vision; cancer health disparity; cancer research center director; collaborative environment; community engagement; diversity and inclusion; education research; equity, diversity, and inclusion; ethnic diversity; experience; improved; member; multimodality; outpatient facility; programs; recruit; research and development; response; success; survivorship; treatment trial; trustworthiness; working group

LEADERSHIP, PLANNING, AND EVALUATION: PROJECT SUMMARY The Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) Senior Leadership and its multi- level planning and evaluation structures are instrumental to the Center’s ability to identify and prioritize new strategic opportunities for growth; perform formative and summative evaluation for all efforts across the MCC research, clinical, and educational domains; and ensure continuous alignment with the Center’s mission, vision, and goals. The MCC Director, Robert A. Winn, MD, who was recruited and appointed in late 2019 as the MCC’s fourth Director since the Center first received National Cancer Institute designation in 1975, leads a Senior Leadership team that includes a Deputy Director and nine Associate Directors who collectively govern as part of an Executive Committee. The Executive Committee fosters a dynamic, inclusive, and interactive environment in which creative planning, rigorous evaluation, targeted investments, and policy developments occur. This Senior Leadership team is guided by a detailed five-year strategic plan, reviewed and revised in late 2020, which was informed by many stakeholders including representatives from the community, Center investigators, VCU leaders, staff, and students/trainees. Seven overarching pillar goals, six core values, articulated disease and mitigating behavioral risk priorities, and dozens of strategies were delineated as part of the 2021-2025 Strategic Plan. Rooted in a Community-to-Bench framework where community engagement is front and center in everything the Center does, the plan also features crosscutting themes focused on addressing cancer disparities and improving survivorship in MCC’s catchment area. The Senior Leadership relies on regular advice and engagement from multiple external advisory entities to evaluate the strategic plan implementation, progress, and milestones; identify resources needed; and refine and add strategies as warranted. These external advisory entities include a Cancer Community Connection Coalition and a Massey Nation Philanthropic Board with members from both serving on a Director’s Community Cabinet and an External Scientific Advisory Board. Internally, the MCC relies on input from its Scientific Steering Committee, comprising Associate Directors and Research Program Leaders and each quarter they are joined by Shared Resource Directors, to guide the oversight and review of research development within and among the programs’ membership, devise approaches to foster transdisciplinary and translational collaborations, and ensure they are supported by the latest technologies and expertise. A few other select advisory Committees providing essential planning and evaluation input to the Director and Senior Leadership include a Research Training and Education Advisory Committee; Diversity, Equity, an Inclusion Guidance Committee; Clinical Research Leadership Committee; and a Cancer Service Line Operational Steering Committee.

领导力、规划和评估：项目摘要 弗吉尼亚联邦大学 (VCU) 梅西癌症中心 (MCC) 高级领导层及其多方合作 水平的规划和评估结构有助于中心识别和优先考虑新的能力 战略增长机会；对整个 MCC 的所有努力进行形成性和总结性评估 研究、临床和教育领域；并确保与中心的使命、愿景、 MCC 董事 Robert A. Winn 医学博士于 2019 年底被任命为 MCC 的董事。 自 1975 年该中心首次获得国家癌症研究所指定以来的第四任主任，领导高级 领导团队包括一名副主任和九名副主任，他们共同管理 执行委员会 执行委员会营造一个充满活力、包容性和互动的环境。 创造性的规划、严格的评估、有针对性的投资和政策的制定。 领导团队以详细的五年战略计划为指导，并于 2020 年底进行了审查和修订，该计划 许多利益相关者提供了信息，包括社区代表、中心调查员、VCU 领导者、工作人员和学生/学员的七个总体支柱目标、六个核心价值观、明确的疾病和 减轻行为风险优先事项，并制定了数十项战略作为 2021-2025 年战略的一部分 计划植根于社区到工作台的框架，其中社区参与是首要和中心。 与该中心所做的一切一样，该计划还具有侧重于解决癌症差异的跨领域主题 提高 MCC 服务区域的生存率依靠的是高级领导层的定期建议和指导。 多个外部咨询实体的参与来评估战略计划的实施、进展和 里程碑；确定所需资源；并根据需要完善和添加战略。 实体包括癌症社区联系联盟和梅西国家慈善委员会 成员均来自主任社区内阁和外部科学咨询委员会。 在内部，MCC 依赖其科学指导委员会的意见，该委员会由副董事和 研究项目负责人以及每个季度都有共享资源总监加入，以指导 监督和审查计划成员内部和之间的研究发展，制定方法 促进跨学科和翻译合作，并确保它们得到最新的支持 一些其他精选的咨询委员会提供必要的规划和评估。 向主任和高级领导层提供的意见包括研究培训和教育咨询委员会； 多样性、公平性、包容性指导委员会和癌症； 服务线运营指导委员会。